Lixian Zhong

Mr. Lixian Zhong

Guangxi Medical University, Nanning, Guangxi, China
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
LZLixian Zhong
Lixian Zhong
SLShun Liu
Shun Liu
XQXiaoqiang Qiu
Xiaoqiang Qiu
XZXiaoyun Zeng
Xiaoyun Zeng
LSLi Su
Li Su
YXYihong Xie
Yihong Xie
The highest prevalence of hyperuricemia was found in Zhuang minority adults in two national surveys in China, with only 1% Zhuang study subjects. However, the prevalence of hyperuricemia and the associated factors in Zhuang adults have not been well-addressed. A cross-sectional study was conducted to explore the prevalence of hyperuricemia and the common comorbidities, and the associated factors in Zhuang adults based on the Guangxi Ethnic Minority Population Cohort. Among 11,175 Zhuang adults aged 35–74 years, the age- and sex-standardized prevalence rate was 18.1% for hyperuricemia and 1.1% for gout. The standardized prevalence rate and awareness rate were 31.6% and 32.3%, respectively, for hypertension, and were 5.1% and 48.2%, respectively, for diabetes. High education level, history of coronary heart disease (CHD), hypertension, being a current drinker, high body mass index (BMI), central obesity, hyper-triglyceride (hyper-TG), hyper-total cholesterol (hyper-TC), hypo-high density lipoprotein cholesterol (hypo-HDL-C), and abnormal aspartate aminotransferase (AST) were risk factors, while smoking and diabetes were protective factors of hyperuricemia in males. Older age, being single/divorced, having a high education level, hypertension, drinking tea, high BMI, central obesity, hyper-TG, hyper-TC, hypo-HDL-C, and abnormal alanine aminotransferase (ALT) were risk factors in females. The high prevalence of hyperuricemia but low prevalence of gout and common comorbidities in Zhuang adults may be due to a lag effect of lifestyle changes. Health education and health management should be strengthened to prevent the progression of comorbidities, considering the lag effect and low awareness rate.

28 September 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YRYuhua Ruan
Yuhua Ruan
THTengda Huang
Tengda Huang
WZWanwan Zhou
Wanwan Zhou
JZJinhui Zhu
Jinhui Zhu
QLQiuyu Liang
Qiuyu Liang
YXYihong Xie
Yihong Xie